A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

This study assessed the safety and preliminary efficacy of escalated dose subcutaneous alemtuzumab in combination with rituximab in chronic lymphocytic leukemia. Twenty-eight patients with relapsed refractory chronic lymphocytic leukemia were treated on four dosing cohorts of weekly rituximab at 375...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Brown, Jennifer R., Messmer, Bradley, Werner, Lillian, Davids, Matthew S., Mikler, Evgeny, Supko, Jeffrey G., Fisher, David C., LaCasce, Ann S., Armand, Philippe, Jacobsen, Eric, Dalton, Virginia, Tesar, Bethany, Fernandes, Stacey M., McDonough, Sean, Ritz, Jerome, Rassenti, Laura, Kipps, Thomas J., Neuberg, Donna, Freedman, Arnold S.
格式: Artigo
語言:Inglês
出版: Ferrata Storti Foundation 2013
主題:
Original Articles and Brief Reports
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669454/
https://ncbi.nlm.nih.gov/pubmed/23645694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.086207
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍